Procter & Gamble (PG) EBT (2009 - 2026)

Procter & Gamble (PG) has reported EBT for 18 consecutive years, with $3.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 13.01% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $20.4 billion, a 1.04% increase from a year earlier, with the FY2026 full-year figure at $20.4 billion, up 1.04% from the prior year.
• EBT was $3.9 billion for Q2 2026 at Procter & Gamble, down from $5.0 billion in the prior quarter.
• Over five years, EBT peaked at $6.0 billion in Q3 2025 and troughed at $3.6 billion in Q2 2022.
• A 5-year average of $4.7 billion and a median of $4.6 billion in 2024 frame the typical range for EBT.
• Across the five-year window, EBT soared 30.0% in 2024 and slipped 13.01% in 2026, its largest moves.
• Over 5 years, EBT stood at $4.8 billion in 2022, then declined by 7.01% to $4.5 billion in 2023, then soared by 30.0% to $5.8 billion in 2024, then dropped by 7.25% to $5.4 billion in 2025, then declined by 27.45% to $3.9 billion in 2026.
• The last three EBT figures came in at $3.9 billion (Q2 2026), $5.0 billion (Q1 2026), and $5.4 billion (Q4 2025), per Business Quant data.